US 8445216
Antibodies and immunotoxins that target human glycoprotein NMB
granted A61KA61K2039/505A61K47/6817
Quick answer
US patent 8445216 (Antibodies and immunotoxins that target human glycoprotein NMB) held by The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health
- Grant date
- Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K47/6817, A61P, A61P29/00